
Organic Process Research and Development p. 1385 - 1392 (2012)
Update date:2022-07-29
Topics:
Mobele, Bingidimi I.
Venkatraman, Sripathy
McNaughton-Smith, Grant
Gibb, Cameron
Ulysse, Luckner G.
Lindmark, Carl A.
Shaw, Stephen
Marron, Brian
Spear, Kerry
Suto, Mark J.
A scalable process for the manufacture of a potassium ion channel blocker was developed and optimized. Key features of the process include an optimized Grignard reaction, a direct cyanation of the intermediate trityl alcohol derivative, and an improved nitrile hydrolysis protocol, relative to the original acidic hydrolysis conditions, to generate the crude active pharmaceutical ingredient (API) with >95% HPLC purity. The Grignard and the cyanation reactions could be telescoped, resulting in an improved throughput compared to the original four-step process. An effective recrystallization of the API was also developed and the process scaled up to manufacture multiple batches at the pilot scale.
View MoreJinan Baozhao Pharmaceutical Co., Ltd
Contact:0086-531-86397156 82371858 82371868
Address:Huaneng Road, Jinan, Shandong ,China
Hubei Danao Pharmaceutical Co.,Ltd.
website:http://www.danaopharm.com
Contact:+86-719-5251167
Address:Fandan Road,Danjiangkou,Hubei
Anyang Double Circle Auxiliary CO.,LTD
Contact:0086-134 6082 4403
Address:dongfeng road, anyang city, henan province,china
Hangzhou TJM Chemical Trade Co., Ltd
Contact:86-571-88223276 86-13388481653
Address:2221#,Boyuexuan,1860# Binsheng Road,Binjiang District, Hangzhou CityZhejiang Province, 310051, P. R. China
CGeneTech (Suzhou, China) Co., Ltd.
Contact:+86-512-62956962
Address:Room 101,Bld C11,218 Xinghu Rd.,Suzhou industrial Park
Doi:10.1007/s10600-012-0257-6
(2012)Doi:10.1039/c2dt30719g
(2012)Doi:10.1021/jo00034a050
(1992)Doi:10.1021/cg300757k
(2012)Doi:10.1016/j.tetlet.2012.06.050
(2012)Doi:10.1016/j.molstruc.2012.02.037
(2012)